Preformulation and Long-Term Stability Studies of an Optimized Palatable Praziquantel Ethanol-Free Solution for Pediatric Delivery
To date, the treatment for cysticercosis and neurocysticercosis consists of a single oral intake of praziquantel (5–10 mg/kg), which since it is only available as tablets, hinders its administration to pediatric patients. Praziquantel is a poorly water-soluble drug which represents a challenge for i...
Main Authors: | Giselle Bedogni, Paula Garcia, Katia Seremeta, Nora Okulik, Claudio Salomon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/8/2050 |
Similar Items
-
Effects of Formulation on the Palatability and Efficacy of In-Feed Praziquantel Medications for Marine Finfish Aquaculture
by: Edith K. Y. Tang, et al.
Published: (2022-05-01) -
Cocrystals of Praziquantel with Phenolic Acids: Discovery, Characterization, and Evaluation
by: Shiying Yang, et al.
Published: (2022-03-01) -
Developing a comprehensive response for treatment of children under 6 years of age with schistosomiasis: research and development of a pediatric formulation of praziquantel
by: Jutta Reinhard-Rupp, et al.
Published: (2017-08-01) -
Preparation and characterisation of Dextran-70 hydrogel for controlled release of praziquantel
by: Flávio dos Santos Campos, et al.
Published: (2013-03-01) -
Praziquantel and Moxidectin pharmacokinetics in dogs after Helmimax administration
by: A. A. Smirnov, et al.
Published: (2023-01-01)